7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
Evidence-based guide to AOD-9604 (HGH fragment 176-191) dosing considerations for Black and African ancestry patients, covering pharmacogenomics, metabolic differences, and clinical monitoring.
A clinical review of AOD-9604 (HGH fragment 176-191) efficacy in East Asian patients, covering pharmacogenomics, BMI threshold differences, and dosing considerations supported by primary literature.
A detailed clinical review of AOD-9604 (HGH fragment 176-191) safety and dosing considerations specific to East Asian patients, covering pharmacogenomics, BMI thresholds, and HLA risk alleles.
A clinical deep-dive into AOD-9604 (HGH fragment 176-191) dosing for Hispanic and Latino patients, covering pharmacogenomics, insulin resistance phenotypes, CYP variant data, and evidence-based dose adjustment strategies.
What can and cannot be concluded about AOD-9604 safety in Hispanic and Latino populations, with FDA regulatory context and limits of the evidence.
A clinical review of AOD-9604 (HGH fragment 176-191) efficacy in Black and African ancestry populations, covering pharmacogenomics, ethnicity-stratified trial data, dosing considerations, and clinical context around hypertension, CKD risk, and G6PD prevalence.
Clinical review of AOD-9604 (HGH fragment 176-191) safety considerations for Black and African ancestry patients, covering pharmacogenomics, dosing, metabolic context, and monitoring gaps.